What Happened to Lane Weaving Among Antidepressant Users Treated Under Three Years?
In the shorter-duration subgroup, sedating-antidepressant users showed a significant increase in lane weaving during an actual highway test. Twenty people treated for less than three years averaged 2.05 cm more SDLP than controls, with a 95% confidence interval from 0.11 to 4.00 cm.
What was compared?
The full study included 38 long-term users of amitriptyline or mirtazapine and 65 controls. Patients had received treatment for at least six months; the authors then divided users at three years of treatment. SDLP measured lateral vehicle-position variability on a standardized one-hour drive in traffic.
Why does the subgroup matter?
The overall 38-patient estimate was not significant, but it combined treatment durations. The shorter-duration result shows why a pooled average can obscure a subgroup pattern. The authors used an alcohol-calibrated performance criterion to discuss clinical relevance; this was not a measured alcohol level in the patients.
What does it not prove?
The study was observational and did not establish that all people before three years are impaired or that the third anniversary restores driving ability. Medication, underlying condition, dose and individual performance still need review in a specific case.
Scientific source: van der Sluiszen NNJJM, Vermeeren A, van Dijken JH, et al. Driving performance and neurocognitive skills of long-term users of sedating antidepressants. Human Psychopharmacology. 2021;36:e2762. doi:10.1002/hup.2762.



